针对性的药物治疗:超越血液计数和化学
Solomea Asfaw1, Samantha Matys2, Benyam Muluneh2
1Children's Hospital of the King's Daughters.
Clinical journal of oncology nursing
|March 21, 2024
概括
瘤学的新型向疗法提供了进步,但引起了副作用. 仔细的实验室监测对于管理癌症药物治疗中的这些意外后果至关重要.
科学领域:
- 在瘤学瘤学.
- 药物治疗 药物治疗
- 临床化学 临床化学
背景情况:
- 瘤学药物治疗领域已经通过新的向疗法迅速发展.
- 这些向疗法虽然有效,但与许多意想不到的副作用有关.
- 为了有效地管理这些副作用,需要对实验室监测参数有很强的了解.
研究的目的:
- 突出实验室监测在管理新型瘤药物疗法的副作用方面的关键作用.
- 强调医疗保健专业人员对这些监测要求的最新知识的需要.
主要方法:
- 对针对性瘤疗法及其相关毒性的当前文献的综述.
- 对常见副作用的实验室监测指南的分析.
- 综合信息,为临床医生提供实用概述.
主要成果:
- 确定监测特定向治疗所需的关键实验室试验.
- 常见副作用与特定实验室异常的相关性.
- 展示实验室监测如何指导治疗调整和毒性管理.
结论:
- 实验室监测对于新型瘤药物疗法的安全和有效使用至关重要.
- 对瘤学家和药剂师来说,对实验室监测的持续教育至关重要.
- 积极的实验室监测可以显著改善患者的治疗结果,并减少与治疗相关的发病率.
更多相关视频
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targets for Drug Action: Overview
6.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.2K
Tumor Immunotherapy
523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K


